tiprankstipranks
Daré Bioscience Inc (DARE)
NASDAQ:DARE

Daré Bioscience (DARE) Financial Statements

1,783 Followers

Daré Bioscience Financial Overview

Daré Bioscience's market cap is currently ―. The company's EPS TTM is $-5.276; its P/E ratio is -0.69; Daré Bioscience is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 9.30K$ 1.00M---
Gross Profit$ 9.30K$ 1.00M---
EBIT$ -6.73M$ -8.25M$ -8.71M$ -8.04M$ -15.94M
EBITDA$ -6.72M$ -8.24M$ -8.70M$ -8.03M$ -15.93M
Net Income Common Stockholders$ -6.80M$ -8.30M$ -8.76M$ -8.04M$ -15.94M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.60M$ 13.90M$ 13.30M$ 19.83M$ 34.67M
Total Assets$ 13.01M$ 25.05M$ 23.18M$ 30.37M$ 43.83M
Total Debt$ 1.64M$ 195.00K$ 295.00K$ 393.00K$ 488.00K
Net Debt$ -1.96M$ -13.71M$ -13.01M$ -19.44M$ -34.18M
Total Liabilities$ 24.01M$ 27.34M$ 25.94M$ 25.37M$ 32.71M
Stockholders Equity$ -11.00M$ -2.29M$ -2.74M$ 4.99M$ 11.11M
Cash Flow-
Free Cash Flow$ -6.82M$ -8.00M$ -6.63M$ -16.08M$ -5.90M
Operating Cash Flow$ -6.81M$ -7.97M$ -6.63M$ -16.08M$ -5.90M
Investing Cash Flow$ -7.30K$ -22.10K--$ -2.70K
Financing Cash Flow$ 14.03K$ 8.58M$ 452.19K$ 1.30M$ -1.00
Currency in USD

Daré Bioscience Earnings and Revenue History

Daré Bioscience Debt to Assets

Daré Bioscience Cash Flow

Daré Bioscience Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis